Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07140510
PHASE4

Dinalbuphine Sebacate in Postoperative Pain Control After TKA

Sponsor: Thammasat University

View on ClinicalTrials.gov

Summary

To evaluate the effectiveness of Dinalbuphine Sebacate for controlling subacute pain after total knee arthroplasty

Official title: Effectiveness of Dinalbuphine Sebacate in Postoperative Pain Control Following Total Knee Arthroplasty: A Randomized Double Blinded Placebo-controlled Trial

Key Details

Gender

All

Age Range

50 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-10

Completion Date

2026-09

Last Updated

2025-08-24

Healthy Volunteers

No

Interventions

DRUG

Dinalbuphine Sebacate

Dinalbuphine Sebacate 150 mg intramuscular injection after spinal anesthesia and adductor canal block in the same side of TKA

DRUG

Normal Saline

Normal saline 2 mL intramuscular injection after spinal anesthesia and adddutor canal block

Locations (1)

Thammasat University

Khlong Luang, Changwat Pathum Thani, Thailand